Clinical data firm Linkdoc raises $102m in D+ round

Linkdoc, a Beijing-based medtech solutions provider that’s focused on oncology, has recently closed a D+ round, bagging 700 million yuan (US$102.39 million) from CICC Capital, CBC Capital, Youshan Capital, iFOF, and other undisclosed existing backers, the company announced Monday.

Photo credit: Michal Jarmoluk

The healthcare unicorn was founded in 2014 by Zhang Tianze, a China Europe International Business School MBA grad, with a mission of digitalizing China’s medical sector. Its products include an AI-assistant diagnosis and management system, patient services, and medical records datasets.

Linkdoc’s services are used by nearly 500 hospitals and 30,000 doctors across the country, with clients also including government departments, pharmaceutical companies, and insurance firms.

The fresh capital will be used for the research and development of new drugs for treating tumors, the establishment of a comprehensive patient service system, the development of an oncology data platform, and insurance payment solutions, according to the announcement.

Prior to this round, Linkdoc closed a 1 billion yuan (US$146.29 million) series D round in July 2018, attracting capital from the state-owned China Investment Corporation. It also counts Ally Bridge Group and US New Enterprise Associates as its investors.

This report was first published on KrAsia.